InvestorsHub Logo
Followers 1
Posts 131
Boards Moderated 0
Alias Born 09/12/2017

Re: carbonfiltered post# 146

Friday, 12/21/2018 2:52:47 PM

Friday, December 21, 2018 2:52:47 PM

Post# of 279
Totally agree DC. Pre-submission meeting with FDA 1/7 for CarpX. After not receiving concurrence from consulting branch in August, company seems to be getting all its ducks lined up and trying to take any doubt for approval out with new experts, lawyers with FDA experience, etc. EsoCheck has been accepted for 510(k) by FDA end of November. It's safe and effective and per CEO - "optimistic that EsoCheck CCD will be cleared expeditiously and available for clinical use in early 2019." Also working with investment bank to partner or sell one or more other devices. I think '19 is the year of Pavmed. I have been loading up on PAVMZ warrants with a 2024 expi date at $.30 - $.33 too. GLTA.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PAVM News